Treatment of cervicogenic headache with application of multicomponent bioregulation drug
Introduction. According to the data of various authors Cervicogenic headache (CH) is met in 2.5 to 70% of population. Diagnostic criteria are described at The International classification of headache (3d revision). CH represents a heterogeneous group of headaches based on functional and organic chan...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2020-07-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/5686 |
| _version_ | 1827961962726686720 |
|---|---|
| author | D. Kh. Khaibullina Yu. N. Maksimov F. I. Devlikamova B. Eh. Gubeev |
| author_facet | D. Kh. Khaibullina Yu. N. Maksimov F. I. Devlikamova B. Eh. Gubeev |
| author_sort | D. Kh. Khaibullina |
| collection | DOAJ |
| description | Introduction. According to the data of various authors Cervicogenic headache (CH) is met in 2.5 to 70% of population. Diagnostic criteria are described at The International classification of headache (3d revision). CH represents a heterogeneous group of headaches based on functional and organic changes of various anatomical structures of the cervical spine. There are no clinical recommendations for the treatment of patients with CH to date.The purpose of this clinical study is the assessment of the effectiveness of use of Traumeel® S in cervicogenic headache treatment.Materials and methods. 60 patients at the age from 18 to 45, divided into 3 groups were examined. Therapy in various combinations was applied to these patients of all the groups. The 2nd and the 3d groups were treated with the Traumeel® S local injection therapy. The patients of the 4th group were additionally given Traumeel® S in sublingual pill form. The visually analogue scale (VAS), the grading scale of the vertebral neurological symptoms, relapse rate of the CH during a year were applied.Results. The most effective treatment was observed in the 2nd group patients. This was manifested in Better dynamics of pain syndrome and the final result. The CH relapse rate during the year of patients treated with Traumeel® S was significantly lower.Conclusions. Traumeel® S inclusion into combined therapy of CH increases the effectiveness of treatment, helps reduce severity of pain, accelerate the appearance of positive therapeutic effect, operates to reduce severity of vertebral neurological symptoms, reduces frequency of recurrence. |
| first_indexed | 2024-04-09T16:35:03Z |
| format | Article |
| id | doaj.art-fd934e1e381d4310bfc989486e07c2ae |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:35:03Z |
| publishDate | 2020-07-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-fd934e1e381d4310bfc989486e07c2ae2023-04-23T06:56:57ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902020-07-01089510110.21518/2079-701X-2020-8-95-1015167Treatment of cervicogenic headache with application of multicomponent bioregulation drugD. Kh. Khaibullina0Yu. N. Maksimov1F. I. Devlikamova2B. Eh. Gubeev3Kazan State Medical AcademyKazan State Medical AcademyKazan State Medical AcademyKazan State Medical AcademyIntroduction. According to the data of various authors Cervicogenic headache (CH) is met in 2.5 to 70% of population. Diagnostic criteria are described at The International classification of headache (3d revision). CH represents a heterogeneous group of headaches based on functional and organic changes of various anatomical structures of the cervical spine. There are no clinical recommendations for the treatment of patients with CH to date.The purpose of this clinical study is the assessment of the effectiveness of use of Traumeel® S in cervicogenic headache treatment.Materials and methods. 60 patients at the age from 18 to 45, divided into 3 groups were examined. Therapy in various combinations was applied to these patients of all the groups. The 2nd and the 3d groups were treated with the Traumeel® S local injection therapy. The patients of the 4th group were additionally given Traumeel® S in sublingual pill form. The visually analogue scale (VAS), the grading scale of the vertebral neurological symptoms, relapse rate of the CH during a year were applied.Results. The most effective treatment was observed in the 2nd group patients. This was manifested in Better dynamics of pain syndrome and the final result. The CH relapse rate during the year of patients treated with Traumeel® S was significantly lower.Conclusions. Traumeel® S inclusion into combined therapy of CH increases the effectiveness of treatment, helps reduce severity of pain, accelerate the appearance of positive therapeutic effect, operates to reduce severity of vertebral neurological symptoms, reduces frequency of recurrence.https://www.med-sovet.pro/jour/article/view/5686cervicogenic headachetreatmenttraumeel® s (tr-14)cervical spinelocal injection therapymyofascial pain syndrometrigger zones |
| spellingShingle | D. Kh. Khaibullina Yu. N. Maksimov F. I. Devlikamova B. Eh. Gubeev Treatment of cervicogenic headache with application of multicomponent bioregulation drug Медицинский совет cervicogenic headache treatment traumeel® s (tr-14) cervical spine local injection therapy myofascial pain syndrome trigger zones |
| title | Treatment of cervicogenic headache with application of multicomponent bioregulation drug |
| title_full | Treatment of cervicogenic headache with application of multicomponent bioregulation drug |
| title_fullStr | Treatment of cervicogenic headache with application of multicomponent bioregulation drug |
| title_full_unstemmed | Treatment of cervicogenic headache with application of multicomponent bioregulation drug |
| title_short | Treatment of cervicogenic headache with application of multicomponent bioregulation drug |
| title_sort | treatment of cervicogenic headache with application of multicomponent bioregulation drug |
| topic | cervicogenic headache treatment traumeel® s (tr-14) cervical spine local injection therapy myofascial pain syndrome trigger zones |
| url | https://www.med-sovet.pro/jour/article/view/5686 |
| work_keys_str_mv | AT dkhkhaibullina treatmentofcervicogenicheadachewithapplicationofmulticomponentbioregulationdrug AT yunmaksimov treatmentofcervicogenicheadachewithapplicationofmulticomponentbioregulationdrug AT fidevlikamova treatmentofcervicogenicheadachewithapplicationofmulticomponentbioregulationdrug AT behgubeev treatmentofcervicogenicheadachewithapplicationofmulticomponentbioregulationdrug |